Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...
The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback